Sign inJoin waitlistJoin the waitlist

Ronald Buckanovich

Medical Oncology · University of Pittsburgh Physicians

Credentials: · · ·

History

UPMC Medical Education
2001–2003
Internal Medicine
1998–2001
Cornell Univ Joan and Sanford I Weill Med Coll
1994–1998

Research

Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study
The Lancet Oncology · 2014 · 479 citations
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
Nature Medicine · 2008 · First of 10 authors · 464 citations
Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival
Cancer Research · 2011 · Last of 12 authors · 432 citations

Lan Coffman
26 papers · 4 as a resident
George Coukos
17 papers · 3 as a fellow
Karen McLean
13 papers · 4 as a fellow
ST
Sarah Taylor
13 papers
Robert Edwards
10 papers
AG
Alison Garrett
7 papers · 4 as a fellow
Paniti Sukumvanich
7 papers
Rinda Soong
7 papers
AO
Alexander Olawaiye
6 papers
Haider Mahdi
6 papers · 5 as a fellow
JL
Jamie Lesnock
6 papers
JB
Jessica Berger
6 papers

Grants

HCC Ovarian Cancer SPORE
National Cancer Institute · P50
Contact PI · $8.8M · University of Pittsburgh at Pittsburgh
2023–2028
Evaluating Unique Aspects of Quiescent Ovarian Cancer Cell Biology for Therapeutic Targets
National Cancer Institute · R01
Contact PI · $1.7M · University of Pittsburgh at Pittsburgh
2023–2028
Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $279.8K · University of Pittsburgh at Pittsburgh
1997–2027
Defining the Impact of Stromal Aging on Ovarian Cancer Initiation
National Institute on Aging · U01
PI · $2.3M · University of Pittsburgh at Pittsburgh
2021–2027

Clinical trials

Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
Principal investigator · Recruiting · Phase 2
Ronald Buckanovich
2023–2032
Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in Gynecologic Patients
Principal investigator · Completed · Phase 2
University of Michigan Rogel Cancer Center
2011–2017